chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 7 weeks late on getting the second dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (7 weeks late on getting the second dose) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (7 weeks late on getting the second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (7 weeks late on getting the second dose) had resolved. Not Provided          No concomitant medications were reported.     No treatment medications were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria, Vaccination site erythema
Clinical narrative: red circle under injection site; itchy bites all over body, possible hives; itchy bites all over body, possible hives; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red circle under injection site), PRURITUS (itchy bites all over body, possible hives) and URTICARIA (itchy bites all over body, possible hives) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle under injection site), PRURITUS (itchy bites all over body, possible hives) and URTICARIA (itchy bites all over body, possible hives). On 24-Mar-2021, VACCINATION SITE ERYTHEMA (red circle under injection site) had resolved. At the time of the report, PRURITUS (itchy bites all over body, possible hives) and URTICARIA (itchy bites all over body, possible hives) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Sex: M
Vaccine: COVID19
Symptoms: Anger, Muscle spasms, Pain in extremity
Clinical narrative: angry; terrible cramping in his left calf; not sure if it is soreness or cramp, but it is pretty much painful , "I don´t know if I have a blood clot or something but I am in constant pain"; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (terrible cramping in his left calf), PAIN IN EXTREMITY (not sure if it is soreness or cramp, but it is pretty much painful , "I don´t know if I have a blood clot or something but I am in constant pain") and ANGER (angry) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced MUSCLE SPASMS (terrible cramping in his left calf) and PAIN IN EXTREMITY (not sure if it is soreness or cramp, but it is pretty much painful , "I don´t know if I have a blood clot or something but I am in constant pain"). On an unknown date, the patient experienced ANGER (angry). At the time of the report, MUSCLE SPASMS (terrible cramping in his left calf), PAIN IN EXTREMITY (not sure if it is soreness or cramp, but it is pretty much painful , "I don´t know if I have a blood clot or something but I am in constant pain") and ANGER (angry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Age: 69.0
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: unable to get second shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (unable to get second shot) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (unable to get second shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (unable to get second shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: vaccine spilled out from opposite of needle onto the arm; needle became disconnected from syringe from deltoid muscle of left arm; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (vaccine spilled out from opposite of needle onto the arm) and DEVICE CONNECTION ISSUE (needle became disconnected from syringe from deltoid muscle of left arm) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (vaccine spilled out from opposite of needle onto the arm) and DEVICE CONNECTION ISSUE (needle became disconnected from syringe from deltoid muscle of left arm). At the time of the report, UNDERDOSE (vaccine spilled out from opposite of needle onto the arm) and DEVICE CONNECTION ISSUE (needle became disconnected from syringe from deltoid muscle of left arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant or treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow- up information received reporter confirmed no adverse event.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain in extremity, Rash, Urticaria
Clinical narrative: hives on face, various areas on body; Rash; redness at the site of injection; hardness at injection site; swelliing at injection site; Redness at the injection site; tiredness; body aches; Arm sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore), URTICARIA (hives on face, various areas on body), RASH (Rash), VACCINATION SITE INDURATION (hardness at injection site) and VACCINATION SITE SWELLING (swelliing at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm sore), FATIGUE (tiredness) and MYALGIA (body aches). On 08-Apr-2021, the patient experienced VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelliing at injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). On 15-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the site of injection). On 03-May-2021, the patient experienced URTICARIA (hives on face, various areas on body) and RASH (Rash). On 20-Apr-2021, PAIN IN EXTREMITY (Arm sore), FATIGUE (tiredness) and MYALGIA (body aches) had resolved. On 11-May-2021, URTICARIA (hives on face, various areas on body) and RASH (Rash) had resolved. At the time of the report, VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelliing at injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment included non-drug treatment- applied ice pack on the affected area.   This case was linked to MOD-2021-131952 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Updated patient demographics. Updated event outcomes for the reported events.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: hives on face, various areas on body; Rash; redness at the site of injection; hardness at injection site; swelliing at injection site; Redness at the injection site; tiredness; body aches; Arm sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore), URTICARIA (hives on face, various areas on body), RASH (Rash), VACCINATION SITE INDURATION (hardness at injection site) and VACCINATION SITE SWELLING (swelliing at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm sore), FATIGUE (tiredness) and MYALGIA (body aches). On 08-Apr-2021, the patient experienced VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelliing at injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). On 15-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness at the site of injection). On 03-May-2021, the patient experienced URTICARIA (hives on face, various areas on body) and RASH (Rash). On 20-Apr-2021, PAIN IN EXTREMITY (Arm sore), FATIGUE (tiredness) and MYALGIA (body aches) had resolved. On 11-May-2021, URTICARIA (hives on face, various areas on body) and RASH (Rash) had resolved. At the time of the report, VACCINATION SITE INDURATION (hardness at injection site), VACCINATION SITE SWELLING (swelliing at injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE ERYTHEMA (redness at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment included non-drug treatment- applied ice pack on the affected area.   This case was linked to MOD-2021-131952 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Updated patient demographics. Updated event outcomes for the reported events.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Gait disturbance, Malaise, Nausea, Pyrexia
Clinical narrative: Walk; Feeling sick; Nausea; chills; fever; little bit chills; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE, MALAISE, PYREXIA, CHILLS, and NAUSEA in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COVID-19. Concomitant products included ASPIRIN, ATORVASTATIN, and DICLOFENAC for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA and CHILLS. On 09-Apr-2021, the patient experienced GAIT DISTURBANCE, MALAISE, NAUSEA, and CHILLS. At the time of the report, GAIT DISTURBANCE, MALAISE, PYREXIA, CHILLS, NAUSEA, and CHILLS outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC-MOD-2021-073717. Sender's Comments:  US-MODERNATX, INC-MOD-2021-073717: Second dose.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Insomnia, Malaise, Myalgia, Rash pruritic
Clinical narrative: soreness of the arm of the injection; felt really bad; rash on the left forearm that was really itchy / Saturday the rash had spread from head to toe.; they had not slept since Friday; felt really ill; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness of the arm of the injection), FEELING ABNORMAL (felt really bad), RASH PRURITIC (rash on the left forearm that was really itchy / Saturday the rash had spread from head to toe.), INSOMNIA (they had not slept since Friday) and MALAISE (felt really ill) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (soreness of the arm of the injection), FEELING ABNORMAL (felt really bad), RASH PRURITIC (rash on the left forearm that was really itchy / Saturday the rash had spread from head to toe.), INSOMNIA (they had not slept since Friday) and MALAISE (felt really ill). The patient was treated with PREDNISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, MYALGIA (soreness of the arm of the injection), FEELING ABNORMAL (felt really bad), RASH PRURITIC (rash on the left forearm that was really itchy / Saturday the rash had spread from head to toe.), INSOMNIA (they had not slept since Friday) and MALAISE (felt really ill) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       List of concomitant medication were not given.   This case was linked to US-MODERNATX, INC.-MOD-2021-073854 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073854:Spouse's case
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue (chronic); This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue (chronic)) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 092L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Fatigue (chronic)). At the time of the report, FATIGUE (Fatigue (chronic)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.  Reportedly, caller agreed to schedule an appointment with HCP.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: Hardness at injection site; Swelling at injection site; Redness at the injection site; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hardness at injection site), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and FATIGUE (Tiredness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE INDURATION (Hardness at injection site), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and FATIGUE (Tiredness). At the time of the report, VACCINATION SITE INDURATION (Hardness at injection site), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information has given as, ice pack. List of concomitant medication were not given.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Pyrexia
Clinical narrative: low grade fever; cough; Tested positive for COVID after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID after vaccination), PYREXIA (low grade fever) and COUGH (cough) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced COVID-19 (Tested positive for COVID after vaccination). On an unknown date, the patient experienced PYREXIA (low grade fever) and COUGH (cough). At the time of the report, COVID-19 (Tested positive for COVID after vaccination), PYREXIA (low grade fever) and COUGH (cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Feeling hot, Headache, Heart rate
Clinical narrative: Itchy; Warm; Fever; Nausea; Headache; Chills; Sore arm around previous TBC vaccine; Swelling around previous TBC vaccine/swollen arm reappear; Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red; Night sweat/night sweat reappear; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm around previous TBC vaccine), PERIPHERAL SWELLING (Swelling around previous TBC vaccine/swollen arm reappear), ERYTHEMA (Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red), NIGHT SWEATS (Night sweat/night sweat reappear) and PRURITUS (Itchy) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: TBC (Received TBC vaccine 30 years ago.) in 1991 and BCG. Past adverse reactions to the above products included No adverse event with BCG and TBC. Concurrent medical conditions included Asthma (Asthma medication, inhaler.).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm around previous TBC vaccine), PERIPHERAL SWELLING (Swelling around previous TBC vaccine/swollen arm reappear), ERYTHEMA (Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red), NIGHT SWEATS (Night sweat/night sweat reappear), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chills). On 09-Apr-2021, the patient experienced PRURITUS (Itchy) and FEELING HOT (Warm). On 02-Apr-2021, PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (Headache) had resolved. On 04-Apr-2021, PAIN IN EXTREMITY (Sore arm around previous TBC vaccine) had resolved. On 11-Apr-2021, NIGHT SWEATS (Night sweat/night sweat reappear) had resolved. At the time of the report, PERIPHERAL SWELLING (Swelling around previous TBC vaccine/swollen arm reappear) and FEELING HOT (Warm) had not resolved, ERYTHEMA (Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red) and PRURITUS (Itchy) had resolved and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Heart rate: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include asthma medication, inhaler.  Treatment for the event included paracetamol.   This case was linked to MOD-2021-128549 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Non significant follow up appended. On 13-May-2021: Case created for 2nd dose of vaccine. Updated patient's contact details. The outcome of the event "Redness" changed (from Not resolved to resolved).
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Night sweats, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Itchy; Warm; Fever; Nausea; Headache; Chills; Sore arm around previous TBC vaccine; Swelling around previous TBC vaccine/swollen arm reappear; Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red; Night sweat/night sweat reappear; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm around previous TBC vaccine), PERIPHERAL SWELLING (Swelling around previous TBC vaccine/swollen arm reappear), ERYTHEMA (Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red), NIGHT SWEATS (Night sweat/night sweat reappear) and PRURITUS (Itchy) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: TBC (Received TBC vaccine 30 years ago.) in 1991 and BCG. Past adverse reactions to the above products included No adverse event with BCG and TBC. Concurrent medical conditions included Asthma (Asthma medication, inhaler.).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm around previous TBC vaccine), PERIPHERAL SWELLING (Swelling around previous TBC vaccine/swollen arm reappear), ERYTHEMA (Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red), NIGHT SWEATS (Night sweat/night sweat reappear), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chills). On 09-Apr-2021, the patient experienced PRURITUS (Itchy) and FEELING HOT (Warm). On 02-Apr-2021, PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (Headache) had resolved. On 04-Apr-2021, PAIN IN EXTREMITY (Sore arm around previous TBC vaccine) had resolved. On 11-Apr-2021, NIGHT SWEATS (Night sweat/night sweat reappear) had resolved. At the time of the report, PERIPHERAL SWELLING (Swelling around previous TBC vaccine/swollen arm reappear) and FEELING HOT (Warm) had not resolved, ERYTHEMA (Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red) and PRURITUS (Itchy) had resolved and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Heart rate: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include asthma medication, inhaler.  Treatment for the event included paracetamol.   This case was linked to MOD-2021-128549 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Non significant follow up appended. On 13-May-2021: Case created for 2nd dose of vaccine. Updated patient's contact details. The outcome of the event "Redness" changed (from Not resolved to resolved).
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Itchy; Warm; Fever; Nausea; Headache; Chills; Sore arm around previous TBC vaccine; Swelling around previous TBC vaccine/swollen arm reappear; Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red; Night sweat/night sweat reappear; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm around previous TBC vaccine), PERIPHERAL SWELLING (Swelling around previous TBC vaccine/swollen arm reappear), ERYTHEMA (Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red), NIGHT SWEATS (Night sweat/night sweat reappear) and PRURITUS (Itchy) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: TBC (Received TBC vaccine 30 years ago.) in 1991 and BCG. Past adverse reactions to the above products included No adverse event with BCG and TBC. Concurrent medical conditions included Asthma (Asthma medication, inhaler.).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm around previous TBC vaccine), PERIPHERAL SWELLING (Swelling around previous TBC vaccine/swollen arm reappear), ERYTHEMA (Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red), NIGHT SWEATS (Night sweat/night sweat reappear), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chills). On 09-Apr-2021, the patient experienced PRURITUS (Itchy) and FEELING HOT (Warm). On 02-Apr-2021, PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (Headache) had resolved. On 04-Apr-2021, PAIN IN EXTREMITY (Sore arm around previous TBC vaccine) had resolved. On 11-Apr-2021, NIGHT SWEATS (Night sweat/night sweat reappear) had resolved. At the time of the report, PERIPHERAL SWELLING (Swelling around previous TBC vaccine/swollen arm reappear) and FEELING HOT (Warm) had not resolved, ERYTHEMA (Redness around previous TBC vaccine/redness on arm reappear/ The scar of BCG turned red) and PRURITUS (Itchy) had resolved and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Heart rate: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include asthma medication, inhaler.  Treatment for the event included paracetamol.   This case was linked to MOD-2021-128549 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Non significant follow up appended. On 13-May-2021: Case created for 2nd dose of vaccine. Updated patient's contact details. The outcome of the event "Redness" changed (from Not resolved to resolved).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Fatigue, Myalgia, Peripheral swelling
Clinical narrative: stomach upset; Puffiness in arm; slight rash over injection site; arm soreness; Chills; tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach upset), PERIPHERAL SWELLING (Puffiness in arm), VACCINATION SITE RASH (slight rash over injection site), MYALGIA (arm soreness) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach upset), PERIPHERAL SWELLING (Puffiness in arm), VACCINATION SITE RASH (slight rash over injection site), MYALGIA (arm soreness), CHILLS (Chills) and FATIGUE (tired). At the time of the report, ABDOMINAL DISCOMFORT (stomach upset), PERIPHERAL SWELLING (Puffiness in arm), VACCINATION SITE RASH (slight rash over injection site), MYALGIA (arm soreness), CHILLS (Chills) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: stomach upset; Puffiness in arm; slight rash over injection site; arm soreness; Chills; tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach upset), PERIPHERAL SWELLING (Puffiness in arm), VACCINATION SITE RASH (slight rash over injection site), MYALGIA (arm soreness) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach upset), PERIPHERAL SWELLING (Puffiness in arm), VACCINATION SITE RASH (slight rash over injection site), MYALGIA (arm soreness), CHILLS (Chills) and FATIGUE (tired). At the time of the report, ABDOMINAL DISCOMFORT (stomach upset), PERIPHERAL SWELLING (Puffiness in arm), VACCINATION SITE RASH (slight rash over injection site), MYALGIA (arm soreness), CHILLS (Chills) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of dyspnea (trouble breathing), pain (body aches), headache and fatigue in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# unknown) for COVID-19 immunization. No medical history reported. On Apr 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced dyspnea (trouble breathing), pain (body aches), headache and fatigue. At the time of the report, dyspnea (trouble breathing), pain (body aches), headache and fatigue outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Visual impairment
Clinical narrative: dizziness/lightheadedness; Vision problem in right eye; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness/lightheadedness) and VISUAL IMPAIRMENT (Vision problem in right eye) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No medical history information reported.  Concomitant products included HYDROXYZINE, TROSPIUM and ESTRADIOL (ESTRING) for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced DIZZINESS (dizziness/lightheadedness) and VISUAL IMPAIRMENT (Vision problem in right eye). At the time of the report, DIZZINESS (dizziness/lightheadedness) and VISUAL IMPAIRMENT (Vision problem in right eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not receive any treatment. Reportedly, the patient said the symptoms were not there at the time of the call, but it comes and go.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pain, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Body ache; Bad dizziness; Headache; Sore arm ( where shot was administered); Vertigo; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Body ache), VERTIGO (Vertigo), DIZZINESS (Bad dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm ( where shot was administered)) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 004C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to dilaudid.). Concomitant products included COLECALCIFEROL (D3) from 2010 to an unknown date, ACETYLSALICYLIC ACID (BABY ASPIRIN) from 2010 to an unknown date, BIOTIN, GLUCOSAMINE & CHONDORITIN from 2010 to an unknown date and UBIDECARENONE (COQ 10) for an unknown indication.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced VERTIGO (Vertigo). On an unknown date, the patient experienced PAIN (Body ache), DIZZINESS (Bad dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm ( where shot was administered)). The patient was treated with Physical therapy (Excercise for vertigo) for Vertigo. On 14-Apr-2021, VERTIGO (Vertigo) had resolved. At the time of the report, PAIN (Body ache), DIZZINESS (Bad dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm ( where shot was administered)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-May-2021, SARS-CoV-2 test: positive (Positive) positive.         Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Significant follow-up : Added concomitant products, vaccine details and events bad dizziness and sore arm ( where shot was administered) having outcomes unknown. Updated stop date and outcome to resolved of event vertigo. Added treatment provided. On 16-Jul-2021: NNI received
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Body ache; Bad dizziness; Headache; Sore arm ( where shot was administered); Vertigo; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Body ache), VERTIGO (Vertigo), DIZZINESS (Bad dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm ( where shot was administered)) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 004C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to dilaudid.). Concomitant products included COLECALCIFEROL (D3) from 2010 to an unknown date, ACETYLSALICYLIC ACID (BABY ASPIRIN) from 2010 to an unknown date, BIOTIN, GLUCOSAMINE & CHONDORITIN from 2010 to an unknown date and UBIDECARENONE (COQ 10) for an unknown indication.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced VERTIGO (Vertigo). On an unknown date, the patient experienced PAIN (Body ache), DIZZINESS (Bad dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm ( where shot was administered)). The patient was treated with Physical therapy (Excercise for vertigo) for Vertigo. On 14-Apr-2021, VERTIGO (Vertigo) had resolved. At the time of the report, PAIN (Body ache), DIZZINESS (Bad dizziness), HEADACHE (Headache) and VACCINATION SITE PAIN (Sore arm ( where shot was administered)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-May-2021, SARS-CoV-2 test: positive (Positive) positive.         Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Significant follow-up : Added concomitant products, vaccine details and events bad dizziness and sore arm ( where shot was administered) having outcomes unknown. Updated stop date and outcome to resolved of event vertigo. Added treatment provided. On 16-Jul-2021: NNI received
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Muscle pain relief; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Muscle pain relief) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Muscle pain relief). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Muscle pain relief) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: internal discomfort (pain almost felt like cramping) in the surgical area; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (internal discomfort (pain almost felt like cramping) in the surgical area) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included Hysterectomy on 30-Mar-2021.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced MUSCLE SPASMS (internal discomfort (pain almost felt like cramping) in the surgical area). On 11-Apr-2021, MUSCLE SPASMS (internal discomfort (pain almost felt like cramping) in the surgical area) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       It is reported that the consumer had a hysterectomy on 30-MAR-2021 and the day after receiving her first dose of the vaccine on 09-APR-2021 she experienced pain that felt like cramping in the surgical area.  She did not seek medical attention for this event but treated this pain with Tylenol and Advil and the pain resolved on 11-APR-2021.  No concomitant medications were reported. No treatment medication details provided.
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: testing positive for Covid; sore throat; trouble swallowing; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), DYSPHAGIA (trouble swallowing) and SARS-COV-2 TEST POSITIVE (testing positive for Covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat) and DYSPHAGIA (trouble swallowing). On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (testing positive for Covid). At the time of the report, OROPHARYNGEAL PAIN (sore throat), DYSPHAGIA (trouble swallowing) and SARS-COV-2 TEST POSITIVE (testing positive for Covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It is reported that the consumer believed she had a head cold but she tested positive for Covid-19. Information pertaining to the Covid-19 test, such as date, and type of test were not provided. No concomitant medications or treatment medications were reported.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: He hives that were very mild; The hives were on his chest ,neck and behind his ear.; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (He hives that were very mild) and URTICARIA (The hives were on his chest ,neck and behind his ear.) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031821A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (He hives that were very mild) and URTICARIA (The hives were on his chest ,neck and behind his ear.). At the time of the report, URTICARIA (He hives that were very mild) and URTICARIA (The hives were on his chest ,neck and behind his ear.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Tinnitus
Clinical narrative: sore arm; buzzing (like static from a tv) in both his ears; really tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), TINNITUS (buzzing (like static from a tv) in both his ears) and FATIGUE (really tired) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002b21a and 024m20a) for COVID-19 vaccination.     No medical history information reported.  Concomitant products included HYDROCHLOROTHIAZIDE, TELMISARTAN (MICARDIS HCT), DILTIAZEM (CARDIZEM [DILTIAZEM]), ZOLPIDEM, CINNAMON [CINNAMOMUM VERUM], TEA, GREEN, VITAMIN D3, FISH OIL, MULTIVITAMIN [VITAMINS NOS], CHONDROITIN SULFATE, GLUCOSAMINE HYDROCHLORIDE, MANGANESE ASCORBATE (COSAMIN), VITAMIN B6, VITAMIN B3, VITAMIN B12 NOS and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), TINNITUS (buzzing (like static from a tv) in both his ears) and FATIGUE (really tired). On 16-Mar-2021, FATIGUE (really tired) had resolved. On 17-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, TINNITUS (buzzing (like static from a tv) in both his ears) had not resolved. Not Provided          No treatment information was provided. The patient has an appointment with health care provider scheduled for 01-May-2021.   This case was linked to US-MODERNATX, INC.-MOD-2021-073700 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073700:1st dose events
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: Headache/ headache began again and is still persistent; Chills/chills returned; Fever/ noticed his fever went up to 102.3; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache/ headache began again and is still persistent), CHILLS (Chills/chills returned) and PYREXIA (Fever/ noticed his fever went up to 102.3) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced CHILLS (Chills/chills returned) and PYREXIA (Fever/ noticed his fever went up to 102.3). On 10-Apr-2021, the patient experienced HEADACHE (Headache/ headache began again and is still persistent). On 12-Apr-2021, CHILLS (Chills/chills returned) and PYREXIA (Fever/ noticed his fever went up to 102.3) had resolved. At the time of the report, HEADACHE (Headache/ headache began again and is still persistent) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 101 (High) Fever of 101. On 10-Apr-2021, Body temperature: 102.3 (High) Fever went up to 102.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Caller stated that after the second dose he started experiencing chills and a fever of 101. Then on 10-Apr-2021 he noticed his fever went up to 102.3 and began experiencing a headache. On 11-Apr-2021, he felt better but then that he stated that his fever came back and had chills, and his headache began again and is still persistent. The chills and fever stopped in the morning of the call.  No treatment information was provided.